サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1771504

米国の腎臓保存の市場規模、シェア、動向分析レポート：保存溶液別、技術別、ドナータイプ別、最終用途別、セグメント予測、2025～2030年

U.S. Kidney Preservation Market Size, Share & Trends Analysis Report By Preservation Solution (University of Wisconsin Solution, Celsior Solution), By Technique (Static Cold Storage), By Donor Type, By End Use, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 125 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
米国の腎臓保存の市場規模、シェア、動向分析レポート：保存溶液別、技術別、ドナータイプ別、最終用途別、セグメント予測、2025～2030年
出版日: 2025年06月05日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の腎臓保存市場の動向：

米国の腎臓保存の市場規模は2024年に2,120万米ドルと推定され、2025～2030年にかけてCAGR 6.97％で成長すると予測されています。

市場成長の原動力は、末期腎不全（ESRD）や糖尿病・高血圧などの慢性疾患の罹患率の上昇などです。腎移植の需要増加も市場成長の原動力となっています。常温機械灌流などの保存技術の進歩は、輸送や保管中の臓器の生存率を高めます。臓器提供プログラムを支援する政府の取り組みも市場をさらに後押ししています。

米国の腎臓保存市場拡大の主な要因は、死亡ドナー移植の一貫した増加であり、これにより信頼性の高い保存溶液に対するニーズが高まっています。例えば、臓器調達・移植ネットワーク（OPTN）によると、米国の死者ドナー移植は2014年の1万2,279件から2024年には2万2,074件に増加しています。最近の動向によると、オピオイド関連死とドナー受け入れ基準の拡大が重なり、死亡ドナーの数が増加しています。臓器調達機関（OPO）は、AKIや合併症を持つドナーなど、さまざまな生理学的プロファイルを持つドナーからの腎臓の回収を優先するため、移植転帰を最適化するためには、高度保存への依存が不可欠となります。さらに、2021年にUNOSが距離ベースの腎臓割り当て政策に移行したことで、臓器分配の地理的半径が拡大し、拡大保存技術の重要性がさらに高まっています。

同様に、米国では腎臓移植の件数が大幅に増加しており、これは予測期間中も続くと予想されるため、高度な腎臓保存溶液に対する需要が高まっています。

さらに、米国の腎臓保存市場の成長は、腎臓提供率の向上を目的とした政府や組織のイニシアチブの増加によっても牽引されています。Advancing American Kidney Health Initiativeなどの連邦プログラムやメディケアメディケイドサービスセンター（CMS）による政策改革は、生存可能な腎臓の回収と利用を増やすよう臓器調達機関（OPO）にインセンティブを与えることで、移植へのアクセスを拡大することを優先しています。

2024年、Gift of Life Donor Programは、947件の腎臓移植をコーディネートし、米国の臓器調達機関をリードし、9年連続で最前線に立ちました。創立50周年を迎えたフィラデルフィアを拠点とするこの団体は、これまでに2万1,000件以上の腎臓移植を促進してきました。様々な組織によるこのような取り組みにより、国内での腎臓提供数はさらに増加すると予想され、それにより予測期間中、保存溶液の需要が促進されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の腎臓保存市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 腎臓保存市場の分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の腎臓保存市場：保存溶液別の推定・動向分析

  • セグメントダッシュボード
  • 米国の腎臓保存市場におけるの変動分析：保存溶液別
  • 米国の腎臓保存市場規模と動向分析：保存溶液別、2018～2030年
  • ウィスコンシン大学（UW）溶液
  • ヒスチジン-トリプトファン-ケトグルタル酸（HTK）溶液
  • セルシオ溶液
  • 高張クエン酸アデニン（HC-A）溶液
  • ジョルジュ・ロペス研究所（IGL-1）溶液
  • その他

第5章 米国の腎臓保存市場：技術別の推定・動向分析

  • セグメントダッシュボード
  • 米国の腎臓保存市場におけるの変動分析：技術別
  • 米国の腎臓保存市場規模と動向分析：技術別、2018～2030年
  • 静的冷蔵保管
  • 低体温機械灌流
  • 常温機械灌流

第6章 米国の腎臓保存市場：ドナータイプ別の推定・動向分析

  • セグメントダッシュボード
  • 米国の腎臓保存市場におけるの変動分析：ドナータイプ別
  • 米国の腎臓保存市場規模と動向分析：ドナータイプ別、2018～2030年
  • 標準基準ドナー（SCD）
  • 拡張基準ドナー（ECD）
  • 脳死後臓器提供（DBD）
  • 循環死後臓器提供（DCD）
  • 生体ドナー

第7章 米国の腎臓保存市場：最終用途別の推定・動向分析

  • セグメントダッシュボード
  • 米国の腎臓保存市場におけるの変動分析：最終用途別
  • 米国の腎臓保存市場規模と動向分析：最終用途別、2018～2030年
  • 移植センター/病院
  • 臓器提供組織（OPO）
  • その他

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • TransMedics Inc.
    • XVIVO
    • Bridge to Life Ltd.
    • Paragonix Technologies Inc.
    • OrganOx Limited
    • Organ Recovery Systems
    • Institut Georges Lopez（IGL）
    • Preservation Solutions, Inc.
    • Global Transplant Solutions
    • Essential Pharmaceuticals LLC
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. kidney preservation market by preservation solution, 2018 - 2030 (USD Million)
  • Table 4 U.S. kidney preservation market by technique, 2018 - 2030 (USD Million)
  • Table 5 U.S kidney preservation market by donor type, 2018 - 2030 (USD Million)
  • Table 6 U.S kidney preservation market by end use, 2018 - 2030 (USD Million)
  • Table 7 Participant's overview
  • Table 8 Financial performance
  • Table 9 Key companies undergoing expansions
  • Table 10 Key companies undergoing acquisitions
  • Table 11 Key companies undergoing collaborations
  • Table 12 Key companies launching new products
  • Table 13 Key companies undergoing partnerships
  • Table 14 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. kidney preservation market: Market outlook
  • Fig. 5 U.S. kidney preservation market: Segment outlook
  • Fig. 6 U.S. kidney preservation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. kidney preservation market driver impact
  • Fig. 9 U.S. kidney preservation market restraint impact
  • Fig. 10 U.S. kidney preservation market, solution outlook key takeaways (USD Million)
  • Fig. 11 U.S. kidney preservation market solution movement analysis 2024 & 2030 (USD Million)
  • Fig. 12 University of Wisconsin (UW) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Histidine-Tryptophan-Ketoglutarate (HTK) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Celsior solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Hypertonic citrate adenine (HC-A) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Institut Georges Lopez-1 (IGL-1) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. kidney preservation market, technique outlook key takeaways (USD Million)
  • Fig. 19 U.S. kidney preservation market technique movement analysis 2024 & 2030 (USD Million)
  • Fig. 20 Static cold storage market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Hypothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Normothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. kidney preservation market, donor type outlook key takeaways (USD Million)
  • Fig. 24 U.S. kidney preservation market donor type movement analysis 2024 & 2030 (USD Million)
  • Fig. 25 Standard Criteria Donor (SCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Expanded Criteria Donor (ECD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Donation after Brain Death (DBD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Donation after Circulatory Death (DCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Living donor market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. kidney preservation market, end use outlook key takeaways (USD Million)
  • Fig. 31 U.S. kidney preservation market end use movement analysis 2024 & 2030 (USD Million)
  • Fig. 32 Transplant centers / hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Organ Procurement Organizations (OPOs) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Heat map analysis
  • Fig. 36 Market participant categorization
  • Fig. 37 U.S. kidney preservation market share analysis, 2024
  • Fig. 38 Strategy framework
目次
Product Code: GVR-4-68040-606-3

U.S. Kidney Preservation Market Trends:

The U.S. kidney preservation market size was estimated at USD 21.2 million in 2024 and is expected to grow at a CAGR of 6.97% from 2025 to 2030. The market growth is driven by several factors, including the rising incidence of end-stage renal disease (ESRD) and chronic conditions such as diabetes and hypertension. The increasing demand for kidney transplants also fuels market growth. Advances in preservation technologies, such as normothermic machine perfusion, enhance organ viability during transportation and storage. Government initiatives supporting organ donation programs further boost the market.

A major driver of the U.S. kidney preservation market's expansion is the consistent rise in deceased donor transplants, which has led to a greater need for reliable preservation solutions. For instance, according to the Organ Procurement & Transplantation Network (OPTN), the deceased donor transplants in the U.S. increased from 12,279 in 2014 to 22,074 in 2024. According to recent trends, the number of deceased donors has increased due to a combination of opioid-related deaths and expanded donor acceptance criteria. As organ procurement organizations (OPOs) prioritize the recovery of kidneys from donors with varying physiological profiles, including those with AKI or comorbidities, reliance on advanced preservation becomes critical to optimize transplant outcomes. Additionally, the 2021 shift to a distance-based kidney allocation policy by UNOS has increased the geographic radius of organ distribution, further intensifying the importance of extended preservation techniques.

Similarly, the number of kidney transplants in the U.S. is witnessing a significant surge, which is expected to continue over the forecast period, thereby increasing the demand for advanced kidney preservation solutions.

Moreover, the growth of the U.S. kidney preservation market is also driven by a rise in government and organizational initiatives aimed at boosting kidney donation rates. Federal programs such as the Advancing American Kidney Health Initiative and policy reforms by the Centers for Medicare & Medicaid Services (CMS) have prioritized expanding access to transplantation by incentivizing organ procurement organizations (OPOs) to increase recovery and utilization of viable kidneys.

In 2024, the Gift of Life Donor Program led U.S. organ procurement organizations by coordinating 947 kidney transplants, marking its ninth consecutive year at the forefront. Celebrating its 50th anniversary, the Philadelphia-based organization has facilitated over 21,000 kidney transplants. Such initiatives by various organizations are further expected to increase the number of kidney donations in the country, thereby driving demand for preservation solutions over the forecast period.

U.S. Kidney Preservation Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. kidney preservation market report based on preservation solution, technique, donor type, and end use.

  • Preservation Solution Outlook (Revenue, USD Million, 2018 - 2030)
  • University of Wisconsin (UW)
  • Histidine-Tryptophan-Ketoglutarate (HTK) Solution
  • Celsior Solution
  • Hypertonic Citrate Adenine (HC-A) Solution
  • Institute Georges Lopez (IGL-1) Solution
  • Others
  • Technique Outlook (Revenue, USD Million, 2018 - 2030)
  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Other
  • Donor Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Standard Criteria Donor (SCD)
  • Expanded Criteria Donor (ECD)
  • Donation after Brain Death (DBD)
  • Donation after Circulatory Death (DCD)
  • Living Donor
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Transplant Centers / Hospitals
  • Organ Procurement Organizations (OPOs)
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Preservation Solution Segment
    • 1.2.2. Technique Segment
    • 1.2.3. Donor Type Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Kidney Preservation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of kidney diseases
      • 3.2.1.2. Growing kidney donations and transplants
      • 3.2.1.3. Growing geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of kidney transplantation
  • 3.3. Kidney Preservation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Kidney Preservation Market: Preservation Solution Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Kidney Preservation Market Preservation Solution Movement Analysis
  • 4.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Preservation Solution, 2018 to 2030 (USD Million)
  • 4.4. University of Wisconsin (UW)
    • 4.4.1. University of Wisconsin (UW) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Histidine-Tryptophan-Ketoglutarate (HTK) Solution
    • 4.5.1. Histidine-Tryptophan-Ketoglutarate (HTK) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Celsior Solution
    • 4.6.1. Celsior Solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hypertonic Citrate Adenine (HC-A) Solution
    • 4.7.1. Hypertonic Citrate Adenine (HC-A) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Institute Georges Lopez (IGL-1) Solution
    • 4.8.1. Institute Georges Lopez (IGL-1) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Kidney Preservation Market: Technique Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Kidney Preservation Market Technique Movement Analysis
  • 5.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 5.4. Static Cold Storage
    • 5.4.1. Static cold storage market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hypothermic Machine Perfusion
    • 5.5.1. Hypothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Normothermic Machine Perfusion
    • 5.6.1. Normothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Kidney Preservation Market: Donor Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Kidney Preservation Market Donor Type Movement Analysis
  • 6.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Donor Type, 2018 to 2030 (USD Million)
  • 6.4. Standard Criteria Donor (SCD)
    • 6.4.1. Standard Criteria Donor (SCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Expanded Criteria Donor (ECD)
    • 6.5.1. Expanded Criteria Donor (ECD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Donation after Brain Death (DBD)
    • 6.6.1. Donation after Brain Death (DBD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Donation after Circulatory Death (DCD)
    • 6.7.1. Donation after Circulatory Death (DCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Living Donor
    • 6.8.1. Living donor market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Kidney Preservation Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Kidney Preservation Market End Use Movement Analysis
  • 7.3. U.S. Kidney Preservation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Transplant Centers / Hospitals
    • 7.4.1. Transplant centers / Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Organ Procurement Organizations (OPOs)
    • 7.5.1. Organ Procurement Organizations (OPOs) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. TransMedics Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. XVIVO
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Bridge to Life Ltd.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Paragonix Technologies Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. OrganOx Limited
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Organ Recovery Systems
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Institut Georges Lopez (IGL)
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Preservation Solutions, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Global Transplant Solutions
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Essential Pharmaceuticals LLC
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives